Tirzepatide is a dual GIP/GLP-1 receptor agonist widely studied in metabolic and diabetes research.
Tirzepatide is a synthetic peptide dual agonist of the GIP and GLP-1 receptors. Supplied as a high-purity lyophilized powder, it is used in laboratory and animal research into glucose metabolism and body-weight regulation. PepNova produces Tirzepatide under a controlled quality system with full batch traceability.
No. All PepNova peptides are strictly for research and animal use, not for human consumption or clinical application.
Lyophilized powder with cold-chain-friendly, discreet packaging. COA and HPLC are included per batch.
Explore more research peptides from PepNova.
Send your target quantity and specification — we'll return a tailored quote and COA sample.
Request a Quote